A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

by | Feb 24, 2026 | Clinical Trials | 0 comments

​ Conditions: Meningioma

Interventions: Drug: Zanzalintinib

Sponsors: Exelixis

Not yet recruiting Conditions: Meningioma
Interventions: Drug: Zanzalintinib
Sponsors: Exelixis
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *